We are live on ! Find out more
AI

Analytic Investors Portfolio holdings

AUM $8.93B
1-Year Est. Return 13.54%
This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+13.54%
3 Year Est. Return
+42.14%
5 Year Est. Return
10 Year Est. Return
AUM
$6.22B
AUM Growth
+$186M
Cap. Flow
+$50.9M
Cap. Flow %
0.82%
Top 10 Hldgs %
20.46%
Holding
730
New
167
Increased
166
Reduced
151
Closed
229

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$125M
2
PEP icon
PepsiCo
PEP
+$64.4M
3
USB icon
US Bancorp
USB
+$59.8M
4
TSN icon
Tyson Foods
TSN
+$49.4M
5
TGT icon
Target
TGT
+$48.9M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$106M
2
APTV icon
Aptiv
APTV
+$34.7M
3
AGNC icon
AGNC Investment
AGNC
+$34.2M
4
NEM icon
Newmont
NEM
+$33.9M
5
GEN icon
Gen Digital
GEN
+$28.3M

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.78%
2 Healthcare 13.79%
3 Financials 11.85%
4 Utilities 10.97%
5 Technology 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
1
Walmart Inc
WMT
$871B
$172M 2.77%
6,980,454
+983,979
+16% +$24.8M
COR icon
2
Cencora
COR
$60.3B
$151M 2.43%
2,468,167
+501,839
+26% +$29.3M
EIX icon
3
Edison International
EIX
$30.7B
$144M 2.32%
3,136,225
+109,558
+4% +$5.18M
T icon
4
AT&T
T
$165B
$126M 2.03%
4,937,448
+4,754,382
+2,597% +$125M
TGT icon
5
Target
TGT
$62.1B
$123M 1.98%
1,922,269
+718,423
+60% +$48.9M
VZ icon
6
Verizon
VZ
$194B
$118M 1.9%
2,526,326
+360,313
+17% +$17.6M
IBM icon
7
IBM
IBM
$202B
$114M 1.84%
645,286
+79,900
+14% +$14.5M
USB icon
8
US Bancorp
USB
$99.6B
$111M 1.78%
3,025,041
+1,614,402
+114% +$59.8M
CLX icon
9
Clorox
CLX
$11.6B
$111M 1.78%
1,353,979
+416,333
+44% +$35.1M
PFE icon
10
Pfizer
PFE
$140B
$101M 1.63%
3,721,433
+1,695,599
+84% +$46.1M
SO icon
11
Southern Company
SO
$110B
$98.2M 1.58%
2,385,095
+626,039
+36% +$27M
PEP icon
12
PepsiCo
PEP
$186B
$95.5M 1.54%
1,201,520
+784,234
+188% +$64.4M
KMB icon
13
Kimberly-Clark
KMB
$36.4B
$95M 1.53%
1,051,112
-83,810
-7% -$7.76M
CAH icon
14
Cardinal Health
CAH
$53.4B
$90.8M 1.46%
1,741,152
+46,276
+3% +$2.35M
MCK icon
15
McKesson
MCK
$98.5B
$88.9M 1.43%
693,064
+151,403
+28% +$18.6M
HSY icon
16
Hershey
HSY
$35.4B
$82.4M 1.33%
890,683
+93,149
+12% +$8.68M
BG icon
17
Bunge Global
BG
$23.6B
$78.6M 1.26%
1,035,540
+210,748
+26% +$16M
LLY icon
18
Eli Lilly
LLY
$1.07T
$77.4M 1.25%
1,538,783
-340,517
-18% -$17.8M
PRE
19
DELISTED
PARTNERRE LTD
PRE
$74.4M 1.2%
812,240
-187,593
-19% -$16.8M
LMT icon
20
Lockheed Martin
LMT
$134B
$68M 1.09%
533,258
-174,409
-25% -$21.2M
EG icon
21
Everest Group
EG
$15.2B
$67.2M 1.08%
462,097
+53,172
+13% +$7.21M
ED icon
22
Consolidated Edison
ED
$41.6B
$66.8M 1.08%
1,212,245
+375,254
+45% +$21.6M
GIS icon
23
General Mills
GIS
$19.2B
$66.5M 1.07%
1,388,384
+714,023
+106% +$35.8M
DTE icon
24
DTE Energy
DTE
$31.1B
$66.4M 1.07%
1,182,613
+143,086
+14% +$8.29M
CVX icon
25
Chevron
CVX
$388B
$66.1M 1.06%
543,823
+7,494
+1% +$921K

Similar funds

Analytic Investors's Q3 2013 Portfolio in Review

As of Q3 2013, Analytic Investors held 730 positions worth $6.22B, up 3.1% from $6.03B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Analytic Investors's Q3 2013 filing shows 167 new, 166 increased, 151 reduced and 229 closed positions. Its largest new stake was T. Rowe Price: 421,030 shares worth $30.3M. The largest sale was Amgen, an estimated $106M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Analytic Investors's largest Q3 2013 buy was T. Rowe Price: 421,030 shares worth $30.3M.
  • Analytic Investors added most to AT&T in Q3 2013, an estimated $125M increase.
  • Analytic Investors's biggest Q3 2013 reduction was Amgen, cutting an estimated $106M.
  • Analytic Investors fully exited Aptiv in Q3 2013, selling an estimated $34.7M.
  • Analytic Investors's ten largest holdings make up 20% of its $6.22B portfolio in Q3 2013.
  • Analytic Investors opened 167 new positions and closed 229 in Q3 2013.
  • Analytic Investors's portfolio value rose 3.1% quarter-over-quarter to $6.22B.

Based on Analytic Investors's 13F filing for Q3 2013, filed 12 Nov 2013.